Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis

<div>Osteoprotegerin and neopterin concentrations were correlated significantly before therapy with adalimumab (a), but not afterwards (b). Patients with additional bisphosphonate therapy are indicated by light grey filled squares.</div>

Disease Markers

fig3

Figure 3

Figure 3: Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis 

Figure 3 | Effects of Antitumor Necrosis Factor Therapy on Osteoprotegerin, Neopterin, and sRANKL Concentrations in Patients with Rheumatoid Arthritis 